(3R,4S,6R)-6-[(3S,4R,6S)-6-[(2S,3R,6R)-6-(2-azidoethoxy)-4,5-bis(phenylmethoxy)-2-(phenylmethoxymethyl)oxan-3-yl]oxy-4,5-bis(phenylmethoxy)-2-(phenylmethoxymethyl)oxan-3-yl]oxy-5-phenylmethoxy-2-(phenylmethoxymethyl)oxane-3,4-diol

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (3R,4S,6R)-6-[(3S,4R,6S)-6-[(2S,3R,6R)-6-(2-azidoethoxy)-4,5-bis(phenylmethoxy)-2-(phenylmethoxymethyl)oxan-3-yl]oxy-4,5-bis(phenylmethoxy)-2-(phenylmethoxymethyl)oxan-3-yl]oxy-5-phenylmethoxy-2-(phenylmethoxymethyl)oxane-3,4-diol
• 化学式: C76H83N3O16
• 分子量: 1294.5
• InChiKey: WNSLKFSDYYPKMQ-MPLIXASMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  10.3
• 重原子数：
  95
• 可旋转键数：
  35
• 环数：
  11.0
• sp3杂化的碳原子比例：
  0.37
• 拓扑面积：
  184
• 氢给体数：
  2
• 氢受体数：
  18

文献信息

• CARBOHYDRATE-LIPID CONSTRUCTS AND THEIR USE IN PREVENTING OR TREATING VIRAL INFECTION
  申请人：Henry Stephen Micheal

  公开号：US20100184723A1

  公开（公告）日：2010-07-22

  The invention relates to selected carbohydrate-lipid constructs and their use as mimics of ligands for receptors expressed by virus. In particular, the invention relates to the use of selected carbohydrate-lipid constructs in methods of inhibiting virus infection and/or promoting clearance of virus from infected subjects. Carbohydrate-lipid constructs selected for use in these methods where the virus is Human Immunodeficiency Virus (HIV) are provided.
• US8211860B2
  申请人：——

  公开号：US8211860B2

  公开（公告）日：2012-07-03